Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine
Status:
Not yet recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
This study is a prospective randomized case-control study. Six hundred patients who were
firstly diagnosed as Helicobacter pylori infection will be selected, and then randomly
assigned into case group and control group. Patients in control group take bismuth
quadruplicate for 14 days. Patients in case group take Ban xia xie xin Decoction and bismuth
agent quadruple for 14 days. Exhalation test or stool Helicobacter pylori antigen detection
were used to assess the eradication rate of Helicobacter pylori 30 days (the 45th day) after
treatment; Adverse reactions were evaluated on the first day (15th day) and the 30th day
(45th day) after treatment. The eradication rate of Helicobacter pylori and the adverse drug
reactions during the medication will be evaluated. The effect of Ban xia xie xin Decoction
and bismuth quadruple based on furazolidone on the eradication of helicobacter pylori
infection will be explored.